NEW YORK, April 09, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of SINOPEC Shangai Petrochemical Company, Ltd. (NYSE:SHI), Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), Valeant Pharmaceuticals International, Inc. (NYSE:VRX), NTT DOCOMO, Inc (NYSE:DCM), Southern Missouri Bancorp, Inc. (NASDAQ:SMBC), and KNOT Offshore Partners LP (NYSE:KNOP), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
SHI DOWNLOAD: http://Fundamental-Markets.com/register/?so=SHI
AUPH DOWNLOAD: http://Fundamental-Markets.com/register/?so=AUPH
VRX DOWNLOAD: http://Fundamental-Markets.com/register/?so=VRX
DCM DOWNLOAD: http://Fundamental-Markets.com/register/?so=DCM
SMBC DOWNLOAD: http://Fundamental-Markets.com/register/?so=SMBC
KNOP DOWNLOAD: http://Fundamental-Markets.com/register/?so=KNOP
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine SINOPEC Shangai Petrochemical Company, Ltd. (NYSE:SHI), Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), Valeant Pharmaceuticals International, Inc. (NYSE:VRX), NTT DOCOMO, Inc (NYSE:DCM), Southern Missouri Bancorp, Inc. (NASDAQ:SMBC), and KNOT Offshore Partners LP (NYSE:KNOP) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed April 6th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
SINOPEC SHANGAI PETROCHEMICAL COMPANY, LTD. (SHI) REPORT OVERVIEW
SINOPEC Shangai Petrochemical's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, SINOPEC Shangai Petrochemical reported revenue of $3,755.10MM vs $2,638.72MM (up 42.31%) and basic earnings per share $2.13 vs $1.44 (up 47.85%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, SINOPEC Shangai Petrochemical reported revenue of $9,923.44MM vs $10,786.29MM (down 8.00%) and basic earnings per share $8.32 vs $4.88 (up 70.67%). SINOPEC Shangai Petrochemical is expected to report earnings on May 1st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $2.58. The estimated EPS forecast for the next fiscal year is $9.51 and is expected to report on April 2nd, 2018.
To read the full SINOPEC Shangai Petrochemical Company, Ltd. (SHI) report, download it here: http://Fundamental-Markets.com/register/?so=SHI
-----------------------------------------
AURINIA PHARMACEUTICALS INC (AUPH) REPORT OVERVIEW
Aurinia Pharmaceuticals' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Aurinia Pharmaceuticals reported revenue of $0.03MM vs $0.03MM (up 3.33%) and basic earnings per share $0.19 vs -$0.22. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Aurinia Pharmaceuticals reported revenue of $0.42MM vs $0.17MM (up 142.77%) and basic earnings per share -$0.92 vs -$0.66. Aurinia Pharmaceuticals is expected to report earnings on May 21st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.20. The estimated EPS forecast for the next fiscal year is -$0.61 and is expected to report on March 21st, 2019.
To read the full Aurinia Pharmaceuticals Inc (AUPH) report, download it here: http://Fundamental-Markets.com/register/?so=AUPH
-----------------------------------------
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (VRX) REPORT OVERVIEW
Valeant Pharmaceuticals International's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Valeant Pharmaceuticals International reported revenue of $2,163.00MM vs $2,403.00MM (down 9.99%) and basic earnings per share $1.46 vs -$1.49. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Valeant Pharmaceuticals International reported revenue of $8,724.00MM vs $9,674.00MM (down 9.82%) and basic earnings per share $6.86 vs -$6.94. Valeant Pharmaceuticals International is expected to report earnings on May 8th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $2.80. The estimated EPS forecast for the next fiscal year is $3.45 and is expected to report on February 27th, 2019.
To read the full Valeant Pharmaceuticals International, Inc. (VRX) report, download it here: http://Fundamental-Markets.com/register/?so=VRX
-----------------------------------------
NTT DOCOMO, INC (DCM) REPORT OVERVIEW
NTT DOCOMO's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, NTT DOCOMO reported revenue of $11,530.39MM vs $10,867.50MM (up 6.10%) and basic earnings per share $0.67 vs $0.46 (up 47.81%). For the twelve months ended March 31st, 2017 vs March 31st, 2016, NTT DOCOMO reported revenue of $42,636.33MM vs $37,574.80MM (up 13.47%) and basic earnings per share $1.63 vs $1.17 (up 38.86%). NTT DOCOMO is expected to report earnings on April 26th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.15. The estimated EPS forecast for the next fiscal year is $1.84 and is expected to report on April 26th, 2018.
To read the full NTT DOCOMO, Inc (DCM) report, download it here: http://Fundamental-Markets.com/register/?so=DCM
-----------------------------------------
SOUTHERN MISSOURI BANCORP, INC. (SMBC) REPORT OVERVIEW
Southern Missouri's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Southern Missouri reported interest income of $19.23MM vs $15.08MM (up 27.50%) and basic earnings per share $0.60 vs $0.56 (up 7.14%). For the twelve months ended June 30th, 2017 vs June 30th, 2016, Southern Missouri reported interest income of $61.49MM vs $56.32MM (up 9.18%) and basic earnings per share $2.08 vs $1.99 (up 4.52%). Southern Missouri is expected to report earnings on April 23rd, 2018. The report will be for the fiscal period ending March 31st, 2018.
To read the full Southern Missouri Bancorp, Inc. (SMBC) report, download it here: http://Fundamental-Markets.com/register/?so=SMBC
-----------------------------------------
KNOT OFFSHORE PARTNERS LP (KNOP) REPORT OVERVIEW
KNOT Offshore Partners LP's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, KNOT Offshore Partners LP reported revenue of $58.22MM vs $43.59MM (up 33.57%) and basic earnings per share $0.64 vs $0.70 (down 8.61%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, KNOT Offshore Partners LP reported revenue of $219.20MM vs $173.67MM (up 26.22%) and basic earnings per share $2.26 vs $2.29 (down 1.18%). KNOT Offshore Partners LP is expected to report earnings on May 15th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.39. The estimated EPS forecast for the next fiscal year is $2.19 and is expected to report on February 19th, 2019.
To read the full KNOT Offshore Partners LP (KNOP) report, download it here: http://Fundamental-Markets.com/register/?so=KNOP
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.